Login / Signup

miRNAs as biomarkers of adverse drug reactions to platinum-based agents in patients with non-small-cell lung cancer.

Pedro Eduardo do Nascimento Silva VasconcelosMarília Berlofa VisacriEder de Carvalho PincinatoNadine de Godoy TorsoCecília S SeguinLair ZambonAristóteles de S BarbeiroMauricio Wesley Perroud JuniorPatricia Moriel
Published in: Biomarkers in medicine (2021)
Keyphrases
  • adverse drug
  • electronic health record
  • emergency department
  • drug induced